European ADULT IMMUNISATION HUB

GSK Seek European Approval for new Shingles Vaccine

GSK have sought European approval for a new Shingles Vaccination. The approval was sought after GSK completed a phase III clinical trial programme evaluating the efficacy, safety and immunogenicity of the new vaccine.

Popular Posts

Sorry. No data so far.